AzTrials
AzTrials

Recurrent Patellar DislocationNCT07785570

Hamstring Versus Quadriceps Tendon Graft for MPFL Reconstruction

An observational study of Recurrent Patellar Dislocation, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This prospective comparative study compared the clinical and radiological outcomes of medial patellofemoral ligament (MPFL) reconstruction using a hamstring tendon graft versus a quadriceps tendon graft in patients with recurrent patellar dislocation. Read more about this study

Who is it for?
Ages 18 to 40 years
Conditions the study is for
Recurrent Patellar Dislocation
What is being tested?
MPFL Reconstruction Using Hamstring Tendon Graft and MPFL Reconstruction Using Quadriceps Tendon Graft
Type of treatment
Surgery or procedure
How many people
38 participants
Where
1 siteEgypt
Study dates
1 Jun 2018to 1 Jun 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: Patients with recurrent patellar instability who underwent medial patellofemoral ligament reconstruction using either a hamstring tendon graft or a quadriceps tendon graft.

Who may be able to join

  • Patients with recurrent patellar dislocation.
  • Age from 18 to 40 years.
  • Patients indicated for isolated medial patellofemoral ligament (MPFL) reconstruction.

Who cannot join

  • Patients with trochlear dysplasia (Dejour B-C-D).
  • Patients with clinical evidence of mal-alignment (varus, valgus, flat foot and femoral anteversion).
  • Patients with congenital pateller dislocation.
  • Patella alta and patella baja.
  • Previous quadriceps muscles operation.
  • Patients with patellofemoral OA.
  • Patients with hypermobility syndrome.
  • Patients with associated pathology.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Cairo University Hospitals (Kasr Al-Ainy)

    Cairo

Other trials in Egypt

About this study

Official title: Comparison Between Hamstring Versus Quadriceps Tendon Graft in MPFL Reconstruction for Recurrent Patellar Dislocation

This prospective comparative study compared the clinical and radiological outcomes of medial patellofemoral ligament (MPFL) reconstruction using a hamstring tendon graft versus a quadriceps tendon graft in patients with recurrent patellar dislocation. The study included 38 patients with 40 affected knees who underwent MPFL reconstruction using either a hamstring tendon graft or a quadriceps tendon graft, according to the treating surgeon's preference. Patients were prospectively followed in two groups according to the graft used. Clinical outcomes were assessed using the Kujala, International Knee Documentation Committee (IKDC), and Tegner-Lysholm scores. Radiological assessment included patellar tilt angle and congruence angle. Postoperative complications and recurrent patellar instability were also evaluated.

Being tested
MPFL Reconstruction Using Hamstring Tendon Graft, MPFL Reconstruction Using Quadriceps Tendon Graft
Keywords
Patellar Instability, Medial Patellofemoral Ligament, MPFL Reconstruction, Hamstring Tendon Graft, Quadriceps Tendon Graft
Medical subject headings
Patellar Dislocation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MPFL Reconstruction Using Hamstring Tendon GraftProcedure or surgery

    Medial patellofemoral ligament reconstruction was performed using an autologous semitendinosus tendon graft. The graft was fixed to the medial aspect of the patella and passed between layers 2 and 3 of the medial knee structures, followed by femoral fixation at the anatomical MPFL insertion.

  • MPFL Reconstruction Using Quadriceps Tendon GraftProcedure or surgery

    Medial patellofemoral ligament reconstruction was performed using a distally based superficial quadriceps tendon graft. The graft remained attached to the superior pole of the patella, was passed between layers 2 and 3 of the medial knee structures, and was fixed at the anatomical femoral insertion of the MPFL.

Study groups in NCT07785570
Study groupRoleWhat they receive
Hamstring Tendon Graft GroupPatients who underwent MPFL reconstruction using a hamstring tendon graft.
Receives: Procedure: MPFL Reconstruction Using Hamstring Tendon Graft
Quadriceps Tendon Graft GroupPatients who underwent MPFL reconstruction using a quadriceps tendon graft.
Receives: Procedure: MPFL Reconstruction Using Quadriceps Tendon Graft

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Kujala score

    Functional outcome assessed using the Kujala anterior knee pain scale. The score ranges from 0 to 100, with higher scores indicating better knee function and fewer patellofemoral symptoms.

    Measured: 12 months postoperatively

Secondary outcomes (5)
  1. International Knee Documentation Committee (IKDC) Score

    Knee function was assessed using the International Knee Documentation Committee (IKDC) score. Scores range from 0 to 100, with higher scores indicating better knee function.

    Measured: 12 months postoperatively

  2. Tegner-Lysholm Knee Score

    Knee function was assessed using the Tegner-Lysholm knee score. Scores range from 0 to 100, with higher scores indicating better knee function.

    Measured: 12 months postoperatively

  3. Patellar Tilt Angle

    Patellar tilt angle was measured radiologically to assess patellofemoral alignment before and after MPFL reconstruction.

    Measured: 12 months postoperatively

  4. Congruence Angle

    Congruence angle was measured radiologically to assess patellofemoral alignment before and after MPFL reconstruction.

    Measured: 12 months postoperatively

  5. Incidence of Re-dislocation

    Number of cases who experienced re-dislocation after MPFL reconstruction

    Measured: 12 months postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Aug 2026
  2. Study start1 Jun 2018
  3. Primary completion1 Jun 2022
  4. Study completion1 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
38 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07785570
Sponsor's protocol ID
N-356-2018
Status last verified
Aug 2026
First submitted
21 Aug 2026
Last updated
25 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Recurrent Patellar Dislocation, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Kujala score (time frame: 12 months postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in